To identify and support young scientists and clinicians with innovative ideas in the field of primary and secondary immunodeficiencies and the role of immunoglobulin therapy
The award program consists of an annual grant of EUR 50,000. Funding is intended to support a 24 month project.
Applications are evaluated based on four criteria:
- Scientific merit
- Clinical / medical impact
- Quality of research environment
Scientists or clinicians up to 45 years of age with an innovative idea relevant to immunodeficiencies and immunoglobulin therapy are invited to apply for the ASPIRE Award. Applications are encouraged from either individuals or research teams who are engaged in research at universities, hospitals, or independent research institutions.
Eligible applicants must submit a CV and a Letter of Intent outlining the aims of their research project. Application letters that fulfill the terms of entry will be assessed and judged by a Review Committee comprised of five experts from healthcare, research, and industry. Based on their review, the Committee will invite several candidates to submit a full research proposal. The Review Committee will evaluate the research proposals and select the award recipient.